HomeSMMT • NASDAQ
add
Summit Therapeutics Inc
Previous close
$17.49
Day range
$17.37 - $17.76
Year range
$15.55 - $36.91
Market cap
13.08B USD
Avg Volume
3.55M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 234.21M | 301.20% |
Net income | -231.79M | -312.05% |
Net profit margin | — | — |
Earnings per share | -0.23 | -276.16% |
EBITDA | -234.17M | -301.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 238.55M | -51.01% |
Total assets | 261.73M | -47.95% |
Total liabilities | 69.47M | 6.98% |
Total equity | 192.26M | — |
Shares outstanding | 744.44M | — |
Price to book | 67.27 | — |
Return on assets | -199.92% | — |
Return on capital | -253.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -231.79M | -312.05% |
Cash from operations | -93.08M | -207.23% |
Cash from investing | -71.00K | 99.93% |
Cash from financing | 33.81M | -83.44% |
Net change in cash | -59.32M | -190.77% |
Free cash flow | -7.19M | 81.80% |
About
Founded
2003
Website
Employees
159
